Ataluren 13C6

[13C6]-Ataluren is a specialized chemical compound that is used in the field of medicinal chemistry. It is a derivative of Ataluren, which is a pharmaceutical drug that is used for treating genetic disorders such as Duchenne muscular dystrophy and cystic fibrosis. [13C6]-Ataluren is essentially a labeled version of Ataluren, which means that it contains six carbon atoms that have been replaced with the stable isotope carbon-13. This labeling helps researchers to track the movement of the drug within the body during clinical trials and experiments. The main function of [13C6]-Ataluren is to promote the production of functional proteins in the body. It works by selectively targeting the ribosomes within cells, which are the molecular machines responsible for producing proteins. By enhancing the accuracy of protein synthesis, [13C6]-Ataluren helps to correct genetic mutations that cause protein misfolding or premature termination. This can lead to improved clinical outcomes for patients suffering from genetic diseases. In terms of chemical properties, [13C6]-Ataluren has a molecular weight of 346.41 g/mol and a chemical formula of C15H8N2O2[13C6]. It is a yellow crystalline powder that is soluble in organic solvents such as DMSO and ethanol. The stability of [13C6]-Ataluren is also an important factor in its usage, as it needs to remain intact during storage and transport for accurate results in clinical trials. Overall, [13C6]-Ataluren is a valuable tool in the field of medicinal chemistry for understanding the mechanisms of protein synthesis and developing effective treatments for genetic diseases.